EUCTR2012-003191-39-GB进行中（未招募）1 期
The effect of a single-dose of d-cycloserine on the basic effects of cognitive-behaviour therapy for panic disorder - a randomized placebo-controlled trial - The effects of d-cycloserine on learning
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Diagnosed with DSM-IV panic disorder
- •At least moderate avoidance of agoraphobic situations (”yes” response to at least 3 situations listed under (2) Avoidance – Do you avoid or feel very uncomfortable in …” in the Structured Panic Assessment Interview (Clark, 1989))
- •Participant is willing and able to give informed consent for participation in the study and to comply with all study requirements.
- •Male or Female, aged 18 years or above.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 46
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 4
排除标准
- •Female participant who is pregnant, breast-feeding, or planning pregnancy
- •CNS-active medication during the last 6 weeks
- •Exposure-based psychological treatment for panic disorder and agoraphobia during the last 3 months
- •Lifetime history of psychosis, bipolar disorder, alcohol, medication or drug abuse or dependence; current primary depressive disorder
- •Lifetime history of epilepsy or other significant disease or disorder which, in the opinion of the investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant’s ability to participate in the study.
- •Insufficient English skills
- •Patient not able to refrain from benzodiazepines 48hrs before treatment and testing sessions
- •Any other significant disease or disorder or circumstance, which, in the opinion of the investigator, may either put the participant at risk or may influence the results of the study or the participant’s ability to participate in the study.
- •Participants with contraindication to MRI scanning (e.g. pacemaker, metal implant, left-handedness) will be included in the study but will not undergo the MRI scan study component.
研究者
相似试验
终止
3 期
D-cycloserine Augmented CBT for Panic DisorderPanic DisorderNCT01680107University of Oxford33
尚未招募
2 期
The effect of the addition of D-cycloserine to exposure sessions in the treatment of patients with obsessive-compulsive disorder.10002861Obsessive-compulsive disorderNL-OMON30642Meerkanten GGZ (Ermelo)40
进行中（未招募）
不适用
The effect of the addition of D-cycloserine to exposure sessions in the treatment of patients with obsessive-compulsive disorder. A randomized, placebo-controlled trial.Obsessive-Compulsive DisorderEUCTR2007-000367-18-NLMeerkanten GGz
尚未招募
4 期
Treatment for public speaking fearsPublic speaking anxietyMental Health - AnxietyACTRN12610000587000Macquarie University140
招募中
2 期
Efficacy of D-Cycloserine in combination with intensive exposure therapy in the treatment of obsessive compulsive disorder (OCD) in childreMental Health - Other mental health disordersPediatric Obsessive Compulsive DisorderACTRN12616000473460Dr Lara Farrell80